ATLAS ARTERIA (ALX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALX

ALX - ATLAS ARTERIA

FNArena Sector : Infrastructure & Utilities
Year End: December
GICS Industry Group : Transportation
Debt/EBITDA: 29.2
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Atlas Arteria, formerly known as Macquarie Atlas Roads, is a global owner, operator and developer of toll roads. It was created and listed in 2010 following the restructuring of the Macquarie Infrastructure Group.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$5.23

03 Sep
2025

-0.040

OPEN

$5.29

-0.76%

HIGH

$5.31

1,984,010

LOW

$5.20

TARGET
$5.342 2.1% upside
OTHER COMPANIES IN THE SAME SECTOR
AGL . AIA . APA . CEN . DBI . DBI . GNE . GNP . MEZ . ORG . SRJ . TCL .
FNARENA'S MARKET CONSENSUS FORECASTS
ALX: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 19.0 33.4 xxx
DPS (cps) xxx 40.0 41.1 xxx
EPS Growth xxx 7.4% 76.2% xxx
DPS Growth xxx 0.0% 2.8% xxx
PE Ratio xxx N/A 15.6 xxx
Dividend Yield xxx N/A 7.9% xxx
Div Pay Ratio(%) xxx 210.7% 122.9% xxx

Dividend yield today if purchased 3 years ago: 5.02%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

7.69

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 24/09 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx19.0
DPS All xxxxxxxxxxxxxxx40.0
Sales/Revenue xxxxxxxxxxxxxxx145.9 M
Book Value Per Share xxxxxxxxxxxxxxx435.1
Net Operating Cash Flow xxxxxxxxxxxxxxx717.9 M
Net Profit Margin xxxxxxxxxxxxxxx188.69 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx4.39 %
Return on Invested Capital xxxxxxxxxxxxxxx3.46 %
Return on Assets xxxxxxxxxxxxxxx3.37 %
Return on Equity xxxxxxxxxxxxxxx4.39 %
Return on Total Capital xxxxxxxxxxxxxxx-0.09 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx136.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx113 M
Long Term Debt xxxxxxxxxxxxxxx1,736 M
Total Debt xxxxxxxxxxxxxxx1,848 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx352 M
Price To Book Value xxxxxxxxxxxxxxx1.09

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx1.1 M
Capex % of Sales xxxxxxxxxxxxxxx0.75 %
Cost of Goods Sold xxxxxxxxxxxxxxx124 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx30 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx5,632 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

29/08/2025

3

Equal-weight

$5.11

(03/09/2025)

-2.29%

Atlas Arteria delivered in line interim 2025 results and confirmed 2025 distribution of 40c with an interim 20c dividend, which was in line with the previous period.

APRR EBITDA rose 3% with a margin of 72.1% versus 72.3% a year ago. Chicago Skyway grew 1% for EBITDA and was below forecast by -2% and missed consensus by -5% due to higher opex.

Dulles Greenway EBITDA rose 10% and slightly beat the analyst's forecast by 1% and met consensus.

Equal-weight. Target price $5.14. Industry view: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY25 dividend of 40.00 cents and EPS of 30.80 cents.
Morgan Stanley forecasts a full year FY26 dividend of 40.00 cents and EPS of 39.90 cents.

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

ALX STOCK CHART